Singapore markets open in 5 hours 42 minutes
Straits Times Index
3,296.89 +4.20 (+0.13%) S&P 500
5,066.14 +47.75 (+0.95%) Dow
38,235.98 +332.69 (+0.88%) Nasdaq
15,843.38 +237.90 (+1.52%) Bitcoin USD
59,190.61 +801.53 (+1.37%) CMC Crypto 200
1,277.07 +6.33 (+0.50%)
Kodiak Sciences Inc. (KOD)
NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
As of 03:18PM EDT. Market open.
| Previous close | 3.5300 |
| Open | 3.5900 |
| Bid | 3.5800 x 200 |
| Ask | 3.6400 x 100 |
| Day's range | 3.4700 - 3.6500 |
| 52-week range | 1.3700 - 9.8000 |
| Volume | |
| Avg. volume | 825,080 |
| Market cap | 189.388M |
| Beta (5Y monthly) | 2.13 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Simply Wall St.
Will Kodiak Sciences (NASDAQ:KOD) Spend Its Cash Wisely?
We can readily understand why investors are attracted to unprofitable companies. For example, although...
- Zacks
Kodiak (KOD) Counts on Tarcocimab Program Despite Setbacks
Kodiak (KOD) initiates a phase III study evaluating tarcocimab in diabetic retinopathy, which is expected to serve as the basis for a regulatory filing for three eye disease indications.
- Insider Monkey
Kodiak Sciences Inc. (NASDAQ:KOD) Q4 2023 Earnings Call Transcript
Kodiak Sciences Inc. (NASDAQ:KOD) Q4 2023 Earnings Call Transcript March 28, 2024 Kodiak Sciences Inc. misses on earnings expectations. Reported EPS is $-1.13 EPS, expectations were $-0.86. Kodiak Sciences Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good day, […]
© 2024 Yahoo. All rights reserved.